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B-Raf and N-Ras proteins are often activated in melanoma, yet their roles in producing inherent survival signals are
not fully understood. In this study, we investigated how N-RASQ61K and B-RAFV600E contribute to melanoma’s
resistance to apoptosis induced by detachment from the extracellular matrix (anoikis). We found that expression of
constitutively active N-RASQ61K and B-RAFV600E downregulated the proapoptotic Bim protein in an immortalized
melanocyte cell line. Bim is one of the main proapoptotic mediators of anoikis. Western blot analysis showed that
detachment increased Bim expression in melanocytes, and Annexin V staining indicated that detachment induced
cell death significantly in melanocytes. Blocking Bim expression by using RNAi vectors or by expressing N-RASQ61K
significantly inhibited anoikis in melanocytes. In summary, this report indicates that N-RASQ61K and B-RAFV600E
contribute to melanoma’s resistance to apoptosis in part by downregulating Bim expression, suggesting that Bim is
a possible treatment target for overriding melanoma’s inherent defenses against cell death.
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INTRODUCTION
Malignant melanoma is a devastating disease as it metasta-
sizes early and is highly resistant to all conventional
treatments, including chemo-, immuno-, or radiation therapy.
Unfortunately, the treatment of this disease has not improved
significantly over the past 30 years. Gaining a better
understanding of the predominant gene alterations and their
downstream signals that occur during melanoma’s initiation
and progression will help to develop effective molecular
targeted strategies for combating the disease.
Activation of Ras or Ras effector pathways is associated
with melanoma initiation and progression (see review
(Chudnovsky et al., 2005; Miller and Mihm, 2006; Gray-
Schopfer et al., 2007)). Two major Ras effector pathways are
important for melanoma development and progression: the B-
Raf/Mek/Erk and the PI3K/Akt pathways (Chudnovsky et al.,
2005; Miller and Mihm, 2006; Gray-Schopfer et al., 2007).
High frequencies of activating mutations in Ras or
members of its effector pathways suggest that these signaling
cascades are important in melanoma tumorigenesis, progres-
sion, and development. The mutation frequency of the Ras
family in human melanoma (mainly N-RAS) has been
estimated at 10–20% (Chudnovsky et al., 2005). Oncogenic
Ras activates both the Raf and PI3K cascades.
In addition to Ras alterations, the discovery of activating
mutations in the B-RaF gene in 80% of short-term melanoma
cell cultures and 66% of uncultured melanomas was the first
success of the Cancer Genome Project (Davies et al., 2002).
A great number of follow-up studies have further investigated
the frequency of B-RAFmutations in melanocytic lesions, and
the resulting estimates have varied from 30 to 70%. Taken
together, the published data suggest that approximately 50%
of melanomas carry the activating B-RAFV600E mutation (see
review (Chudnovsky et al., 2005)).
In a review on apoptosis regulation and melanoma
resistance to therapies, Soengas and Lowe (2003) indicated
that during melanoma progression, malignant cells become
‘‘bullet proof’’ against a variety of chemotherapeutic drugs by
exploiting their intrinsic apoptotic defenses and by repro-
gramming their proliferation and survival pathways (Soengas
and Lowe, 2003).
Both activating N-RAS and B-RAF mutations have been
demonstrated to be very important for melanoma survival as
suppression of either of them by RNA interference induces
apoptosis in human melanoma cells (Hingorani et al., 2003;
Eskandarpour et al., 2005).
Decreased sensitivity to anoikis, or detachment-induced
cell death, has been shown to be a characteristic of
oncogenic progression in epithelial cells (Reginato et al.,
2005). Adhesion of cells to appropriate extracellular matrix is
important for the survival of many normal cells and the tissue
organizations of multicellular organisms, and anoikis is
considered as the mechanism by which cells use extracellular
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matrix-derived signals to maintain tissue integrity in vivo
(see review (Gilmore, 2005)). The insensitivity of cells
to anoikis has been suggested to be associated with epithelial
to mesenchymal transition, transformation, and immortaliza-
tion (see review (Gilmore, 2005)).
The Bcl-2 family of proteins is crucial in regulating
apoptosis (see review (Thomadaki et al., 2006)), and the
proapoptotic BH3-only protein member, Bim, has been
shown to be important in detachment-induced apoptosis
(anoikis) in mammary epithelial cells, epidermal keratino-
cytes, and NIH3T3 cells (Reginato et al., 2003; Marani et al.,
2004; Wang et al., 2004; Collins et al., 2005; Quadros et al.,
2006; Woods et al., 2007).
Here, we investigated the role of Bim in regulating anoikis
in human melanocytic cells, and how active N-Ras and B-Raf
contribute to their resistance to anoikis by regulating Bim
expression. We found that detachment significantly induced
Bim-mediated apoptosis in immortalized human melano-
cytes. In addition, N-RASQ61K or B-RAFV600E provides
protection from anoikis for the cells by the activation of
mitogen-activated protein kinase (MAPK) signaling and the
subsequent repression of Bim protein expression.
RESULTS
Overexpressed HA-tagged B-RAFV600E, myr-AKT3, and
N-RASQ61K were functionally active in PIG1 melanocytes
To examine the functions of active B-Raf, Akt, and N-ras in
melanoma development, we transiently transfected PIG1
cells, an immortalized human melanocyte cell line (Le Poole
et al., 1997), with vectors containing constitutively active
hemagglutinin (HA)-tagged B-RAFV600E, myr-AKT3, and
N-RASQ61K. We have achieved 60–90% transfection efficiency
routinely estimated by fluorescence-activated cell sorting
staining with anti-HA-Alexa488 antibody (data not shown).
Further, western blotting confirmed strong expression of HA-
tagged proteins in PIG1 cells (Figure 1a). As active B-Raf and N-
Ras should upregulate phospho-p44/42 MAPK (p-p44/42 MAPK
or p-Erk) expression, and active N-Ras and Akt3 should
upregulate phospho-Akt expression, we performed western Blot
analyses of p-p44/42 MAPK (Thr202/Tyr204) and phospho-Akt
(Ser473) to determine whether the transfected proteins were
functionally active in PIG1 cells. Figure 1a shows that indeed all
transfected proteins were functionally active. For example,
expression of B-RafV600E and N-RasQ61K but not myr-AKT3
significantly upregulated p-p44/42 MAPK protein level com-
pared to the control. In addition, expression of N-RasQ61K and
myr-AKT3 but not B-RafV600E drastically upregulated phospho-
Akt protein levels compared to the control. The smaller
molecular weight of HA-myr-Akt3 compared to wild-type Akt
is due to the truncation of the active myr-Akt3 construct.
Overexpression of B-RAFV600E and N-RASQ61K but not
myr-AKT3 downregulated Bim expression in PIG1
melanocytes grown in monolayer culture
We used western blotting to examine whether overexpression
of B-RafV600E, myr-AKT3, and N-RasQ61K regulate Bcl-2 family
members in PIG1 cells grown in monolayer culture. We found
that overexpression of B-RafV600E or N-RasQ61K but not myr-
AKT3 downregulated Bim protein expression significantly
(Figure 1b) compared to other Bcl-2 family members (Figure S1).
Figure 1b also shows that the Bim-EL protein band in B-RafV600E
or N-RasQ61K transfectants migrated slightly slower, indicating
that they are phosphorylated forms.
Detachment-induced Bim expression and apoptosis in PIG1
melanocytes, and knocking down Bim expression protected
PIG1 cells partially from anoikis
Bim has been shown to be important in detachment-induced
apoptosis (anoikis) in mammary epithelial cells, epidermal
keratinocytes, and NIH3T3 cells (Reginato et al., 2003; Marani
et al., 2004; Wang et al., 2004; Collins et al., 2005; Quadros
et al., 2006; Woods et al., 2007). Growing cells on poly-(2-
hydroxyethylmethacrylate) (poly-HEMA)-coated dishes prevent
attachment and have been shown to induce anoikis (Reginato
et al., 2003; Marani et al., 2004; Wang et al., 2004; Collins
et al., 2005; Quadros et al., 2006; Woods et al., 2007).
To assess whether Bim expression is involved in anoikis in
human melanocytes, we used shRNA retroviral vectors to
knock down Bim expression specifically in PIG1 cells. We
transduced PIG1 melanocytes with retroviral vectors
encoding Bim shRNA or Control shRNA (shControl), and
then cultured the stable pools of cells in growth factor-free
medium on normal or poly-HEMA-coated dishes to induce
N-RasAktB-RafCont.
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p-p44/42 MAPK
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Figure 1. Transfection of PIG1 melanocytes with active BRaf and NRas
decreased Bim protein expression in monolayer culture. PIG1 cells were
transiently transfected with expression vectors pMEV-2HA(a) (Control),
pMEV-2HA-BRAF-V600E (Braf), pMEV-2HA-AKT3-Myr (Akt), or pMEV-2HA-
NRAS-Q61K (NRas), and grown in monolayer culture for 24 hours before
being subjected to indicated analysis. (a) Western Blot analysis for the
activation of downstream signaling. (b) Western Blot analysis of Bim
expression in transfected PIG1 cells grown in monolayer. Three putative
isoforms of Bim are indicated by arrows, with Bim-EL at top, Bim-L in the
middle, and Bim-S at bottom.
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anoikis. Figure 2a shows that detachment (cultured in poly-
HEMA-coated dishes) decreased MAPK signaling activity in
all PIG1 cells, as indicated by reduced expression of the
phospho-p44/p42 MAPK protein. In addition, detachment
induced Bim protein expression in both PIG1 parental and
PIG1 shControl cells. However, expression of Bim shRNA in
PIG1 cells dramatically reduced Bim protein levels in both
monolayer and detachment conditions compared to both
parental and shControl PIG1 cells.
We then performed Annexin V apoptosis assays to
quantify total apoptotic cells induced by detachment in these
cell lines (Figure 2b). Both parental (54.8%±3.6) and
shControl (53.1%±4.1) PIG1 cells exhibited significantly
higher cell death, compared to Bim shRNA (39.5%±3.3)
PIG1 cells (n¼7; analysis of variance (ANOVA); P¼0.01).
This decrease of 13.6% in the death rate constitutes 26% of
relative cell death when the death rate in shControl cells is set
as 100%. These results suggest that anoikis in human
melanocytes cells is in part mediated by Bim upregulation.
Overexpressing HA-tagged N-RasQ61K in PIG1 melanocytes
inhibited detachment-induced Bim protein expression and
apoptosis
We transfected PIG1 melanocytes with expression vectors
encoding HA-tagged N-RasQ61K (NRas) or the empty vector
control (Control) and cultured them in growth factor-free
medium on poly-HEMA-coated dishes for indicated times.
Figure 3a illustrates that PIG1 cells transfected with
N-RasQ61K exhibited significantly higher MAPK signaling
activity, as shown by increased expression of the phospho-
p44/p42 MAPK protein. Further, Bim protein expression was
reduced in active N-Ras transfectants compared to vector
control transfectants, and the Bim-EL protein band migrated
slightly slower in those samples. We note that the degree of
Bim downregulation by active N-Ras was less in poly-HEMA
culture than in monolayer culture.
We then performed Annexin V apoptosis assays to
quantify apoptotic cell death in transfected PIG1 cells grown
for 48 hours in poly-HEMA-coated dishes (Figure 3b). HA-N-
RasQ61K-transfected PIG1 cells (NRas; 41.5%±4.1) showed
significantly less apoptosis compared to empty vector-
transfected PIG1 cells (Control; 55.1%±3.4) (n¼5; ANOVA;
P¼0.001). This is a 25% reduction of relative cell death.
DISCUSSION
Dysregulation of apoptosis is a hallmark of cancer develop-
ment and the Bcl-2 family proteins are major regulators of
apoptosis. Bim is a BH3-only proapoptotic member of the
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Figure 2. Detachment induced Bim expression and apoptosis and
knocking-down Bim expression provided survival signals against anoikis.
PIG1 cells were transduced with retroviral vectors encoding Bim shRNA (shBim)
or Control shRNA (shControl), and stable pools were then grown in normal or
poly-HEMA-coated dishes in medium without growth factors for indicated
times. (a) Protein expression in PIG1 parental and transduced cell lines grown
for 24 hours in monolayer (without poly-HEMA) or detachment (with poly-
HEMA) culture conditions. (b) Annexin V apoptosis assays for PIG1 parental and
transduced cell lines grown for 48 hours in poly-HEMA culture conditions.
Averages represent seven independent experiments (P¼0.01 by ANOVA).
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Figure 3. Transfection of PIG1 melanocytes with active NRas decreased Bim
expression and apoptosis induced by detachment. PIG1 melanocytes were
transiently transfected with pMEV-2HA-NRAS-Q61K (NRas) or pMEV-2HA(a)
(Control) vectors, and grown in poly-HEMA-coated dishes using medium
without growth factors for indicated times. (a) Immunoblots. The Bim ratio
refers to Bim protein expression levels as normalized to Tubulin levels.
(b) Annexin V apoptosis assay for transfected PIG1 melanocytes grown for
48 hours in poly-HEMA-coated dishes. Averages represent five independent
experiments (P¼ 0.001 by ANOVA).
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Bcl-2 family, and it can antagonize all the pro-survival Bcl-2
proteins, leading to apoptosis. Bim is one of the main
proapoptotic mediators of anoikis in normal cells (Reginato
et al., 2003; Marani et al., 2004; Wang et al., 2004; Collins
et al., 2005; Quadros et al., 2006; Woods et al., 2007).
In this study, we examined whether N-RASQ61K and
B-RAFV600E regulate expression levels of Bcl-2 family
members and how this might be involved in melanoma’s
resistance to apoptosis, specifically anoikis. Transient trans-
fection experiments with a human melanocyte cell line PIG1
indicated that B-RAFV600E and N-RASQ61K downregulated the
proapoptotic Bim protein (Figure 1), and conversely MEK
inhibition in melanoma cells upregulated Bim protein
expression (data not shown). Our results suggest that
constitutively activated MAPK signaling in melanoma cells
suppresses expression of the proapoptotic Bim protein.
Figure 2 shows that detachment-induced anoikis in the
human melanocyte cell line, PIG1, which was at least
partially Bim-mediated. In addition, expression of N-RASQ61K
in these cells protected them from this anoikis significantly
(Figure 2). Figure 4 illustrates our hypothesis: detachment
significantly induced Bim-mediated apoptosis in human
melanocytes. In addition, N-RASQ61K or B-RAFV600E provides
protection from anoikis by the activation of MAPK signaling
and the subsequent repression of Bim protein expression.
Normal melanocytes are kept in the correct tissue
compartment by proper cell–extracellular matrix interactions
for survival. When melanoma progresses to more advanced
stages, cells invade into the dermis that does not provide
the normal cell–extracellular matrix survival signals
required for melanocyte survival. Our results suggest that
N-RASQ61K or B-RAFV600E in melanoma might be one of the
factors that provide these protections by downregulation of
the proapoptotic protein Bim when cells invade into the
dermis.
Although knocking down Bim in PIG1 cells protected cells
from anoikis, it was not sufficient to rescue the cells completely
(Figure 2). Our data suggest that Bim is not the only mediator of
anoikis in melanocytes. It has been recently shown that Bad is
also involved in anoikis in melanoma cells (Boisvert-Adamo
and Aplin, 2008). In addition, Bmf upregulation and Mcl-1
degradation have also been implicated in anoikis in certain
cells (Puthalakath et al., 2001; Woods et al., 2007). The roles
of these proteins will be investigated in future studies.
Figure 1b also shows that the Bim-EL protein band in
N-RASQ61K or B-RAFV600E transfectants migrated slightly
slower, resembling to the phosphorylated form of Bim-EL
seen by others (Harada et al., 2004; Tan et al., 2005).
Harada et al. (2004) have demonstrated that phosphorylation
of Bim by MAPK (Erk) can inhibit Bim’s proapoptotic
activity. It is conceivable that B-RAF600E and N-RASQ61K
initiate this stream of events by activating Erk, and inducing
downstream phosphorylation events leading to inactivation
of Bim.
In other cell types, including human mammary epithelial
cells and Chinese hamster lung fibroblast cells, it has been
reported that activation of MAPK (Erk) signaling pathways
promotes phosphorylation and proteasome-dependent degra-
dation of Bim (Ley et al., 2003; Reginato et al., 2003).
Oncogenes such as ERbB2, v-Src, and H-Ras, suppress
expression of Bim by an MAPK-dependent pathway, con-
tributing to cell transformation and resistance to chemother-
apy (Reginato et al., 2005; Tan et al., 2005). However, our
report describes the link between Bim and the Ras/B-Raf/Erk
signaling pathway in human melanocytic cells.
These results are consistent with a very recent study
(Boisvert-Adamo and Aplin, 2008), in which the authors used
melanoma cell lines to show that Bim and Bad are major
B-RAF responsive proteins that regulate resistance to anoikis.
Our results complement theirs, and they indicate that Bim is
one of the Ras/B-Raf/Erk responsive proteins that regulates
apoptosis in melanocytic cells.
High frequencies of activating mutations in B-RAF or
N-RAS are found in melanoma that probably contributes to
constitutive MAPK (Erk) signaling. Our data suggest that low
expression of Bim might be quite common in melanomas.
Indeed, Dai et al.(2008) reported that Bim expression is
reduced as melanoma progresses, and decreased Bim
expression is also significantly correlated with poor 5-year
survival in melanoma patients. Results here and by others
suggest that Bim is a possible treatment target for overriding
cancer’s inherent defenses, including melanomas.
Several studies support the concept of Bim as a treatment
target in cancers, including melanoma (Tan et al., 2005;
Deng et al., 2007; Kashiwagi et al., 2007). For example,
Kashiwagi et al. (2007) utilized a synthetic peptide called
TAT-Bim (containing the BH-3 domain from Bim) to treat
various cancer cells and found that it induced apoptosis in a
dose-dependent fashion in many cancer cell lines in vitro,
and it significantly slowed tumor growth in murine models of
pancreatic cancer and melanoma. These studies indicate that
reversing the low levels of Bim expression in cancer cells can
be exploited to develop new treatments.
In summary, our study indicates that N-RASQ61K and
B-RAFV600E contribute to melanoma’s resistance to apoptosis,
such as anoikis, in part by downregulating Bim expression.
Because of the high frequency of B-RAFV600E and N-RASQ61K
mutations in melanomas, more studies are warranted for
developing rational therapies that address low expression
levels of the proapoptotic protein Bim in these cells.
Normal
Detachment
Transfected
Detachment N-Ras MAPK Bim
(Others)
Survival
(Others)
AnoikisBimMAPK
Figure 4. Constitutively active MAPK signaling protects melanocytic cells
from Bim-mediated anoikis. (a) In melanocytes, detachment reduces MAPK
signaling, which allows Bim expression levels to increase that leads to
anoikis. (b) Expression of N-RASQ61K activates MAPK signaling, which
suppresses Bim induction and results in cell survival.
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MATERIALS AND METHODS
Cell lines and culture conditions
An immmortalized human melanocyte cell line, PIG1, was kindly
provided by Dr Le Poole (Le Poole et al., 1997). Cells were
maintained in Medium 254 with Human Melanocyte Growth
Supplement-2 (Cascade Biologics, Portland, OR) and antibiotics, in
a 5% CO2 incubator at 37 1C. The medical ethical committee of
University of Colorado Denver approved all the described studies.
Constructs
The following expression plasmids employing the human cytome-
galovirus immediate-early promoter were obtained from Biomyx
Technology (San Diego, CA): the empty vector (pMEV-2HA, reading
frame A), and a vector encoding activated human B-RAF (pMEV-
2HA-BRAF-V600E). To facilitate detection of the protein of interest,
these vectors use two 9-amino-acid peptides (HA) derived from the
hemagglutinin influenza virus as an N-terminal affinity tag. The
myristoylated human Akt3 expression vector (pMEV-2HA-AKT3-
Myr) was made by PCR subcloning the myristoylated human Akt3
gene sequence from the vector pcDNA3.1/myc-his-hAKT3myr
(kindly provided by Kohsuke Kanekura, KEIO University School of
Medicine, Tokyo, Japan) (Kanekura et al., 2005) into pMEV-2HA
(reading frame A) at the NheI and XmaI restriction sites. The standard
PCR protocol was used for PCR amplifying the myristoylated human
Akt3 gene with the following primers: AKT3myr NheI, forward:
50-GCGCTAGCATGGGGAGTAGCAAGAGCAAGC and AKT3myr
XmaI, backward: 50-GCCCCGGGTTATTCTCGTCCACTTGCAGAG.
The activated human N-RAS expression vector (pMEV-2HA-NRAS-
Q61K) was made by PCR subcloning the activated human N-RAS
gene sequence from the vector pZIPneoSV(x)1-NRas-61K (kindly
provided by Channing Der, University of North Carolina at Chapel
Hill, Chapel Hill, NC) (Plattner et al., 1996) into pMEV-2HA (reading
frame A) at the BamHI and EcoRI restriction sites. The standard PCR
protocol was used for PCR amplifying the activated N-RAS gene
using the following primers: NRas BamHI, forward: 50-CGGGATC
CATGACTGAGTACAAACTGGTG and NRas EcoRI, backward:
50-GCGAATTCTTACATCACCACACATGGCAA. All resulting clones
were verified by sequencing at UCDHSC cancer center sequencing
core. The pMAX-GFP vector was obtained from Amaxa Inc.
(Gaithersburg, MD) for optimizing nucleofection conditions.
The pSUPER.Retro.Puro vector containing the human H1 RNA
promoter for expressing shRNA was purchased from Oligoengine
(Seattle, WA). Validated mRNA target sequences were selected to
generate DdRNAi oligonucleotide inserts for all isoforms of human
BIM (GenBank AF032457, nucleotides 37–56; GACCGAGAAGG
TAGACAATT; (Lu et al., 2006)), and a nontargeting control sequence
(AATTCTCCGAACGTGTCACGT; (Lu et al., 2006)) using Oligoen-
gine’s software. The annealed inserts were cloned into the
BglII/HindIII sites of pSUPER.Retro.Puro according to Oligoengine’s
protocol, and all vectors were confirmed by sequencing in the
University of Colorado Cancer Center DNA Sequencing and
Analysis Core.
Reagents
poly-HEMA was purchased from Sigma Chemical (St Louis, MO).
Poly-HEMA was suspended in 95% ethanol at a final concentration
of 12mgml1, and dissolved overnight at 65 1C. The MEK inhibitor
U0126 was purchased from Promega (Madison, WI) and was
dissolved in dimethyl sulfoxide before use. A final concentration of
10 mM U0126 was used to treat the cells.
Anoikis growth
Culture dishes were coated with 1.5ml (6-cm dish) and 5ml (10-cm
dish) poly-HEMA (12mgml1) that had been previously dissolved in
ethanol at 65 1C. Dishes were allowed to dry at least overnight in an
empty 37 1C incubator, to ensure all ethanol had evaporated. PIG1
cells were plated at densities of 6 105 cells per 6-cm dish, whereas
nucleofected PIG1 cells were plated at densities of one reaction per
6-cm dish and two reactions per 10-cm dish.
Transient transfection
Plasmids were introduced into cells by nucleofection, using an
Amaxa Nucleofector II device (Amaxa Inc.). For PIG1, we used two
million cells and 20 mg of DNA per reaction, using Amaxa’s Reagent
V and program T-020. PIG1 cells were cultured in 6-cm dishes after
nucleofection.
Generation of stable cell lines with retroviral transduction
Phoenix amphitropic packaging cells were transiently transfected
with pSUPER vectors using FuGENE 6 (Roche Diagnostics, Indiana-
polis, IN) according to the manufacturer’s protocol, and allowed to
produce virus for 48 hours. Viral supernatants were filtered using
0.45-mM polyethersulfone filters and added to target cells for 24 hours
in the presence of 5mgml1 Polybrene (hexadimethrine bromide;
Sigma Chemical). Target cells were allowed to recover in normal
growth medium for 24 hours, and infection was repeated two more
times for a total of three rounds. At 24 hours after the third infection,
puromycin (Sigma Chemical) at 0.5mgml1 was added for at least 5
days to select stably transduced pools of cells. For all experiments,
the stable pool of nontargeting control cells was used.
Immunoblot
At 24 hours after nucleofection, adherent cells were washed once
with phosphate-buffered saline (PBS) and lyzed directly in the dish
with 0.15ml of 1 Laemmli Sample Buffer (Bio-Rad, Hercules, CA).
Cells from poly-HEMA-coated plates were centrifuged at 1,000 g. for
5 minutes, rinsed with PBS, centrifuged again, and lyzed directly in
centrifuge tubes using 0.10ml of 1 Laemmli Sample Buffer.
Lysates were heated at 95 1C for 5–10 minutes and then clarified by
centrifugation at 13,200 g for 5 minutes. Samples were electrophor-
esed on SDS–PAGE 4–20% acrylamide gradient gels (Bio-Rad), and
transferred to p olyvinylidene difluoride membranes using a
Transblot SD Semi-Dry Transfer Cell apparatus (Bio-Rad) at 15V
for 30 minutes. Membranes were probed with primary antibodies in
PBS with 5% nonfat milk, washed with PBS for 5 minutes, Tris-
buffered saline/Tween for 2 10 minutes, then PBS for 5 minutes,
and incubated with horseradish peroxidase (HRP)-conjugated
secondary antibody in PBS with 5% nonfat milk. Blots were
developed with HRP substrate (West Pico or Femto developing
solutions; Pierce, Rockford, IL) for 5 minutes at room temperature,
and analyzed using a Chemi-doc chemiluminescence detector (Bio-
Rad). The following antibodies were used at the suggested dilutions
from each manufacturer: anti-Bim rabbit polyclonal antibody was
from Chemicon/Millipore (Billerica, MA); anti-phospho-Akt (Ser473),
anti-HA-Tag, and anti-phospho-p44/42 MAPK (Thr202/Tyr204)
mouse monoclonal antibodies were from Cell Signaling Technology
Inc. (Beverley, MA); anti-Actin and anti-Noxa mouse monoclonal
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antibodies were from EMD Biosciences Inc. (San Diego, CA); HRP-
conjugated goat anti-rabbit IgG was from Transduction Laboratories
(Lexington, KY); HRP-conjugated goat anti-mouse IgM was from
EMD Biosciences Inc.; HRP-conjugated goat anti-mouse IgG was
from Jackson ImmunoResearch (West Grove, PA).
Annexin V apoptosis assay
The Annexin V-FITC Apoptosis Detection Kit was purchased from
BD Biosciences (San Jose, CA) and cells were stained at indicated
times according to the manufacturer’s protocol. Cells were analyzed
by flow cytometry using a Beckman Coulter FC500 with CXP
software (Beckman Coulter, Hialeah, FL) in the University of
Colorado Cancer Center Flow Cytometry Core. ANOVAs were
performed to compare group means.
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